MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-10-2026
Electromed Total Current Liabilities 2011-2026 | ELMD
Annual Total Current Liabilities Electromed
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.5 M | 7.68 M | 8.05 M | 7.15 M | 4.64 M | 2.99 M | 3.62 M | 4.74 M | 2.9 M | 3.07 M | 2.28 M | 1.82 M | 2.19 M | 4.17 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.5 M | 1.82 M | 4.7 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Helius Medical Technologies
HSDT
|
1.88 M | $ 2.13 | -1.39 % | $ 1.29 M | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 11.44 | 3.81 % | $ 410 M | USA |
 |
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
18 M | $ 3.49 | 4.49 % | $ 131 M |  France |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Inspire Medical Systems
INSP
|
96.1 M | $ 46.15 | -15.91 % | $ 1.36 B | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 11.25 | 0.63 % | $ 319 M | USA |
 |
LivaNova PLC
LIVN
|
808 M | $ 57.82 | -2.12 % | $ 3.15 B |  Britain |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.63 | 0.87 % | $ 39.2 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
13.2 M | $ 1.07 | -1.38 % | $ 18.1 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
Insulet Corporation
PODD
|
680 M | $ 169.07 | -1.35 % | $ 11.9 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 16.05 | 1.71 % | $ 377 M | USA |
 |
Sintx Technologies
SINT
|
3.73 M | $ 2.38 | 0.42 % | $ 6.6 M | USA |
 |
Butterfly Network
BFLY
|
48.2 M | $ 4.96 | 2.37 % | $ 1.05 B | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
498 M | $ 91.09 | 0.54 % | $ 12.3 B | USA |
 |
NanoVibronix
NAOV
|
6.66 M | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 36.07 | 0.45 % | $ 1.12 B | USA |
 |
Integer Holdings Corporation
ITGR
|
232 M | $ 86.83 | 3.36 % | $ 3.02 B | USA |
 |
TransMedics Group
TMDX
|
89.3 M | $ 96.34 | -0.76 % | $ 3.27 B | USA |
 |
Stryker Corporation
SYK
|
7.79 B | $ 295.54 | 1.54 % | $ 113 B | USA |
 |
Tandem Diabetes Care
TNDM
|
243 M | $ 19.25 | -3.12 % | $ 1.31 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 82.79 | -0.65 % | $ 48.4 B | USA |
 |
LENSAR
LNSR
|
40.6 M | $ 5.51 | -0.9 % | $ 65.9 M | USA |
 |
Pulmonx Corporation
LUNG
|
20.1 M | $ 1.26 | -5.26 % | $ 51.3 M | USA |
 |
MiMedx Group
MDXG
|
64.3 M | $ 3.71 | 2.77 % | $ 548 M | USA |
 |
Myomo
MYO
|
8.35 M | $ 0.85 | -1.1 % | $ 35.6 M | USA |